Vasculitis - Lefu La Vasculitishttps://en.wikipedia.org/wiki/Vasculitis
Lefu La Vasculitis (Vasculitis) ke sehlopha sa mathata a senyang methapo ea mali ka ho ruruha. Vasculitis e ka aroloa ho latela sesosa, sebaka, mofuta oa sekepe kapa boholo ba sekepe. Ho ka 'na ha hlokahala liteko tsa laboratori le biopsy ea letlalo ho fumana lisosa tsa motheo. Hangata liphekolo li lebisitsoe ho thibela ho ruruha le ho hatella sesole sa 'mele. Ka tloaelo, corticosteroids tse kang prednisone li sebelisoa.

Tlhahlobo
Vasculitis e lekanyelitsoeng letlalong e ka ntlafala ha nako e ntse e ea. Leha ho le joalo, liteko tsa mali le moroto li ka etsoa ho fumana mathata a systemic kapa autoimmune.

Kalafo - Lithethefatsi tsa OTC
Haeba vasculitis e lekanyelitsoe letlalong ntle le ho hlaseloa ke litho tse ling, ho ka sebelisoa setlolo sa steroid.
#OTC steroid ointment
☆ Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
  • Mathata a mang a tsamaiso (mafu a autoimmune) a amang vasculitis a lokela ho qheleloa ka thoko.
  • Ena ke setšoantšo se tloaelehileng sa vasculitis ea leoto. Teko ea moroto e ka etsoa ho hlahloba ho se tloaelehe ha tšebetso ea liphio.
  • Livedo vadculopathy
  • Purpura
  • Henoch schonlein purpura
References An aetiological & clinicopathological study on cutaneous vasculitis 22382191 
NIH
Of the 61 patients studied, hypersensitivity vasculitis (HSV) [23 (37.7%)] and Henoch Schonlein purpura (HSP) [16 (26.2%)] were the two most common forms. Systemic involvement was seen in 32 (52.45%) patients. Drugs were implicated in 12 (19.7%) cases, infections in 7 (11.4%) and connective tissue disorders in 4 (6.5%) cases. No association was seen between history of drug intake and tissue eosinophilia and also between histologically severe vasculitis and clinical severity.
 Leukocytoclastic Vasculitis 29489227 
NIH
Leukocytoclastic vasculitis ke mofuta oa ho ruruha ha letlalo ho amang methapo e menyenyane ea mali e ka har'a letlalo. E ka etsahala ka mabaka a sa tsejoeng kapa a amahanngoa le tšoaetso, lihlahala, mafu a autoimmune, kapa meriana. Matšoao a tloaelehileng a kenyelletsa matheba a khubelu kapa a pherese maotong, ho ameha ha likepe tse nyenyane, 'me maemong a ka bang 30 lekholong, likarolo tse ling tsa' mele le tsona lia ameha. Linyeoe tse ngata li itokisa ka botsona ka mor'a libeke tse 'maloa ho isa likhoeling. Kalafo e fapana ho latela hore na e matla hakae, ho tloha ho fokotsa butle-butle oral corticosteroids ho ea ho sebelisa lithethefatsi tse ling tse fokotsang ho ruruha ntle le li-steroid.
Leukocytoclastic vasculitis is a cutaneous, small-vessel vasculitis of the dermal capillaries and venules. This condition can be idiopathic or can be associated with infections, neoplasms, autoimmune disorders, and drugs. Key clinical features of leukocytoclastic vasculitis include palpable purpura on the lower extremity, small vessel involvement, and, in about 30 percent of individuals, extracutaneous involvement. Most cases of idiopathic cutaneous, small vessel vasculitis are self-limited with 90 percent of cases resolving in weeks to months of onset. Otherwise, treatment depends on the severity of disease and can range from an oral corticosteroid taper to various steroid-sparing immunosuppressive agents.